BK vs MCRB · P/E 17, $94.14B cap vs rev $1.1M
The Bank of New York Mellon Corporation (BK) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the BK and MCRB stock pages for the full models.
Not investment advice.